Close Menu

NEW YORK (GenomeWeb) – Genome analysis company Genomics plc said today that it has closed a £25 million ($32.5 million) Series B funding round.

Vertex Pharmaceuticals led the round with a £10.5 million equity investment as part of a new, multiyear R&D partnership with Genomics. The IP Group, Woodford Investment Management, Invesco Perpetual, Oxford Sciences Innovation, Lansdowne Partners, and Tanarra also participated in the Series B.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.